About Us | Contact Us |        

Optimizing Patient Care in NSCLC: A Targeted Patient-Centered Approach


Optimizing Patient Care in NSCLC: A Targeted Patient-Centered Approach

Topic: Hematology-Oncology
Relevant Terms: Non-small cell lung cancer (NSCLC)
Primary Audience: Physicians, nurse practitioners, physician assistants, and registered nurses
Launch Date: 02-Feb-16
Credits: AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Optimizing Patient Care in NSCLC: A Targeted Patient-Centered Approach

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Utilize a comprehensive understanding of histopathologic and molecular underpinnings of non-small cell lung cancer (NSCLC) and efficacy and safety data for agents used to treat NSCLC to select the most appropriate personalized therapies
  2. Implement the most effective treatment strategies for patients with NSCLC using current evidence-based guidelines for sequencing, combination chemotherapy, and targeted therapy
  3. Engage patients with NSCLC in their healthcare by implementing effective shared decision-making strategies


    Daniel Morgensztern, MD
    Associate Professor of Medicine
    Director, Thoracic Medical Oncology
    Washington University School of Medicine
    St. Louis, MO
    Jared Weiss, MD
    Assistant Professor of Medicine
    University of North Carolina Lineberger Comprehensive Cancer Center
    Chapel Hill, NC
    H. Jack West, MD
    Medical Director, Thoracic Oncology Program, Swedish Cancer Institute
    Web Editor, JAMA Oncology
    Founder and President, GRACE: Global Resource for Advancing Cancer Education
    Seattle, WA
    Accreditation Statement
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and RMEI, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
    Credit Designation
    The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
    The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
    • Daniel Morgensztern, MD, has affiliations with Celgene, Genentech, and Heat Biologics (Consulting); and Boehringer Ingelheim and Genentech (Speaker).
    • Jared Weiss, MD, has affiliations with AstraZeneca, Biodesix, Clovis Oncology, Eli Lilly, EMD Serono, and OncoPlex (Consulting); and AstraZeneca, Celgene, Merck, Novartis, and Pfizer (Research).
    • H. Jack West, MD, has affiliations with ARIAD, AstraZeneca, Boehringer Ingelheim, Genentech/Roche, Guardant Health, and Novartis (Consulting); and Boehringer Ingelheim (Non-CME/CE Services).
    • Sherri Lanza, MD, has no affiliations with commercial interests to disclose.
    • Amy Reeve has no affiliations with commercial interests to disclose.
    Postgraduate Institute for Medicine
    The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, MSN, RN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 
    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
    Estimated time to complete: 1.0 hour
    Medium: Internet

    There is no fee for this educational activity.

    This activity is supported by independent educational grants from Genentech and Lilly.

    By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive up to 1.0 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the post-test and activity evaluation.
    You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
    Supported Browsers:
    Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1
    Google Chrome 28.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
    Safari 6+ for Mac OSX 10.7 and above
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above